4.2 Review

What's been Hapten-ing over the last 88 years?

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis

Samantha Christine Sernoskie et al.

Summary: The risk of idiosyncratic drug-induced agranulocytosis (IDIAG) limits the use of clozapine, but most clozapine patients experience an early inflammatory response, which is likely a necessary step in IDIAG onset. Clozapine activates inflammasomes and myeloperoxidase bioactivates clozapine to generate neoantigens, suggesting a connection between these events and IDIAG.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Detection of Hepatic Drug Metabolite-Specific T-Cell Responses Using a Human Hepatocyte, Immune Cell Coculture System

Serat-E Ali et al.

Summary: This study utilized metabolite-responsive T-cells and primary human hepatocytes to establish a hepatocyte immune cell coculture system for detecting metabolite formation and metabolite-specific T-cell responses. The results showed that metabolites could be transferred between hepatocytes and immune cells and stimulate T-cell proliferation. This study demonstrates the use of hepatocyte immune cell coculture systems for detecting in situ metabolite formation and metabolite-specific T-cell responses.

CHEMICAL RESEARCH IN TOXICOLOGY (2023)

Review Pharmacology & Pharmacy

Recent progress in targeting KRAS mutant cancers with covalent G12C-specific inhibitors

Lala S. Rathod et al.

Summary: KRASG12C has been identified as a potential target in the treatment of solid tumors, and despite being considered an 'undrugable' target for a long time, sustained research efforts on the KRASG12C mutant protein have achieved promising results. The FDA has granted emergency approval for sotorasib and adagrasib for the treatment of metastatic lung cancer, sparking new approaches to KRASG12C.

DRUG DISCOVERY TODAY (2023)

Article Immunology

Activation of Human CD8+T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides

Mubarak Almutairi et al.

Summary: Previous studies have shown that cysteine-reactive drug metabolites can activate patients' T cells. In this study, nitroso dapsone-modified HLA-B*13:01 binding peptides were designed and synthesized to explore their immunogenicity in allergic patients. The results showed that these modified peptides could bind to specific HLA molecules and activate CD8+ T cell clones. The study also revealed cross-reactivity between nitroso dapsone-modified peptides with cysteine residues in different positions.

JOURNAL OF IMMUNOLOGY (2023)

Review Immunology

Antigen discovery for the development of cancer immunotherapy

Ryuhjin Ahn et al.

Summary: Effective T cell antitumor immunity is essential for successful cancer immunotherapy. Mass spectrometry-based survey of tumor antigens (immunopeptidomics) combined with other omics platforms has contributed to the identification and quantification of T cell antigens. This review discusses the types of tumor antigens for targeted cancer immunotherapy and the importance of immunopeptidomics methods in MHC peptide identification. It also highlights the integration of mass spectrometry-driven approaches with other technologies in the discovery of targetable T cell antigens for cancer immunotherapy.

SEMINARS IN IMMUNOLOGY (2023)

Review Immunology

Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example

Cheryl F. Lichti et al.

Summary: In autoimmune diseases, self-antigens presented by MHC molecules trigger attacks on tissues by autoantibodies and/or autoreactive T cells. Mass spectrometry-based immunopeptidomics can identify MHC ligands with post-translational modifications, providing valuable insights into the pathogenesis and therapeutics of autoimmune diseases. This review highlights the formation and identification of various post-translational modifications implicated in autoimmune diseases.

SEMINARS IN IMMUNOLOGY (2023)

Review Immunology

The impact of immunopeptidomics: From basic research to clinical implementation

Ilja E. Shapiro et al.

Summary: The immunopeptidome is a collection of peptides presented by MHC molecules on the surface of cells involved in T-cell immunosurveillance. It provides information about the cellular health state and is influenced by various factors. Immunopeptidomics is the method used to extract and analyze these peptides, giving insights into the immunopeptidome.

SEMINARS IN IMMUNOLOGY (2023)

Review Immunology

Viral T-cell epitopes - Identification, characterization and clinical application

Sarah M. Schroeder et al.

Summary: T-cell immunity is crucial for controlling viral infections, and it involves the CD4+ and CD8+ T cells. The viral T-cell epitopes, which are viral peptides presented by human leukocyte antigen (HLA) on virus-infected cells, are essential for T cell recognition of infected cells. Understanding viral T-cell epitopes not only offers a diagnostic tool to study protective T-cell responses in the human population, but also provides potential prophylactic and therapeutic options, such as vaccination and transfer of virus-specific T cells. These approaches have demonstrated effectiveness against various viral infections, especially in immunocompromised patients with insufficient antibody-based immune responses.

SEMINARS IN IMMUNOLOGY (2023)

Article Toxicology

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury

Serat-E Ali et al.

Summary: Flucloxacillin, a beta-lactam antibiotic, is associated with a high incidence of drug-induced liver injury. This study found that Flucloxacillin can bind to multiple proteins in human primary hepatocytes, including major hepatocellular proteins and mitochondrial proteins. These Flucloxacillin-modified intracellular proteins could potentially serve as a source of neoantigens for HLA-B*57:01 presentation by hepatocytes.

TOXICOLOGICAL SCIENCES (2023)

Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Toxicology

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity

Sean Hammond et al.

Summary: An emerging clinical issue associated with immune-oncology agents is their impact on the tolerability of concomitant medications. This study aimed to investigate the role of T cells in hypersensitivity reactions observed in patients receiving immune checkpoint inhibitors (ICIs) and sulfasalazine (SLZ). The results showed that drug-responsive T cells are effectors of these adverse events, and perturbation of drug-specific T-cell priming may explain the increased incidence of these reactions.

TOXICOLOGICAL SCIENCES (2022)

Review Allergy

The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions

Werner J. Pichler

Summary: Drug hypersensitivity reactions are characterized by abnormal immune stimulation driven by non-covalent drug-protein interactions, including mimicry, increased antibody affinity, and p-i stimulation. These interactions can lead to various complications such as viral reactivations, autoimmunity, and multiple drug hypersensitivity.

ALLERGY (2022)

Article Medicine, General & Internal

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

J. H. Strickler et al.

Summary: This study evaluated the safety and efficacy of sotorasib in patients with KRAS p.G12C-mutated pancreatic cancer who had previously received treatment. The results showed that sotorasib demonstrated anticancer activity and had an acceptable safety profile in these patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Chemistry, Medicinal

Idiosyncratic Drug Reactions: A 35-Year Chemical Research in Toxicology Perspective

Jack Uetrecht

Summary: The founding of Chemical Research in Toxicology has played an important role in the study of idiosyncratic drug reactions (IDRs). Reactive metabolites and immune mechanisms have been investigated in IDRs, but there are differences in the mechanisms and pharmacological effects caused by different drugs. Studying the innate immune response may provide a more accurate way to screen drugs for their potential to cause IDRs.

CHEMICAL RESEARCH IN TOXICOLOGY (2022)

Article Cell Biology

Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity

Haiqin Jiang et al.

Summary: This study investigates the molecular mechanisms of HLA-B*13:01 in the pathogenesis of Dapsone-induced drug hypersensitivity. The crystal structure of HLA-B*13:01-beta-2-microglobulin complex is determined, and key residues mediating the binding of DDS are identified. Single-cell TCR and RNA sequencing indicate that clonotype-specific TCRs can recognize HLA-B*13:01-DDS complex to trigger inflammatory cytokines associated with DDS-DIHS.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Article Allergy

Drug-specific T-cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat

Paul J. Thomson et al.

Summary: The study aimed to generate and characterize atabecestat(metabolite)-responsive T-cell clones from patients with liver injury. CD4(+) T-cell clones activated via a pharmacological interactions pathway in patients with liver injury suggest an immune-based mechanism for the observed hepatic enzyme elevations.

ALLERGY (2021)

Article Allergy

Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis

Rosamund Sara Casimir-Brown et al.

Summary: The study found that hypersensitivity reactions caused by piperacillin/tazobactam are more common in patients with cystic fibrosis. Patients with negative skin test results but having allergies still tolerated reintroduction of the drug, and most patients exhibited selectively sensitized and tolerated other penicillins.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Review Oncology

KRAS mutation in pancreatic cancer

Ji Luo

Summary: Pancreatic cancer is a difficult-to-treat cancer with low survival rates, commonly driven by oncogenic mutations in the KRAS gene. Therapeutic strategies targeting mutant KRAS show promise but face challenges in achieving clinical efficacy.

SEMINARS IN ONCOLOGY (2021)

Article Immunology

Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides

Montserrat Puig et al.

Summary: The interaction between flucloxacillin (FLX) and HLA-B*57:01 may lead to the formation of neoantigens, causing severe hypersensitivity reactions. FLX treatment diversifies the immunopeptidome of cells, enriching it with drug-modified peptides that induce specific CD8(+) T cell responses. FLX-modified lysines on peptides may impact interactions with KIR or TCR, affecting NK and T cell function.

FRONTIERS IN IMMUNOLOGY (2021)

Article Dermatology

HLA Class-II. Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients

Qing Zhao et al.

Summary: HLA-B*13:01 is associated with dapsone-induced hypersensitivity. CD8+ T cell clones from hypersensitive patients were generated and showed that DDS and its metabolite DDS-NO activate T cells. DDS and DDS-NO interact with multiple HLA molecules, and certain CD8+ T cell clones with HLA class-II restriction also contribute to the immune response in patients.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Immunology

Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire

Patricia T. Illing et al.

Summary: Abacavir hypersensitivity syndrome occurs in individuals with a specific gene expression, altering immune responses. Research shows that abacavir affects the assembly of HLA-B*57:01 complexes.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs

Sean Hammond et al.

Summary: Mitigating the risk of drug hypersensitivity reactions is crucial, with efforts over the past 50 years resulting in the development of assays at all stages of a drug's lifespan, from lead compound selection to clinical use. This includes intelligent compound design, preclinical studies on biological interactions, and accurate diagnoses during clinical use for effective patient management and safety optimization.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The rise of covalent proteolysis targeting chimeras

Ronen Gabizon et al.

Summary: Targeted protein degradation through PROTACs has advantages over direct protein inhibition, but faces challenges such as limited E3 ligase selection and the need for strong target binding. Covalent PROTACs have the potential to expand target and E3 ligase pools, improve complex formation kinetics, and provide additional selectivity to degraders.

CURRENT OPINION IN CHEMICAL BIOLOGY (2021)

Article Immunology

Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells

Vittoria Massafra et al.

Summary: This study explores the potential of targeted protein degradation in tumor cells to enhance T cell effector function, and for the first time investigates the impact of combining a degrader and a TCB in cancer immunotherapy.

JOURNAL OF IMMUNOLOGY (2021)

Article Toxicology

Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01

Monday O. Ogese et al.

Summary: This study demonstrates the importance of HLA-A*32:01 expression in priming T cells with vancomycin, leading to stronger responses. CD8+ T cells are activated through a direct binding interaction with vancomycin, with evidence of cross-reactivity with other antibiotics like teicoplanin.

TOXICOLOGICAL SCIENCES (2021)

Review Biochemistry & Molecular Biology

The role of reversible and irreversible covalent chemistry in targeted protein degradation

Hannah Kiely-Collins et al.

Summary: PROTACs are an exciting technology in chemical biology and drug discovery that degrade disease-causing proteins by hijacking the endogenous ubiquitin-proteasome system. This review explores the role of reversible and irreversible covalent chemistry in targeted protein degradation, highlighting the key advantages of targeted covalent inhibitors. They enhance the selectivity of PROTACs, enable access to more of the undruggable proteome, and expand the repertoire of recruited E3 ligases.

CELL CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC

Lydia Boike et al.

Summary: A covalent ligand, EN4, has been identified that can directly target MYC in cells, reduce MYC and MAX thermal stability, inhibit MYC transcriptional activity, downregulate multiple MYC transcriptional targets, and impair tumorigenesis. This study reveals a novel ligandable site within an intrinsically disordered region of MYC that leads to inhibition of MYC transcriptional activity.

CELL CHEMICAL BIOLOGY (2021)

Article Chemistry, Medicinal

Predicting Drug-Induced Liver Injury with Bayesian Machine Learning

Dominic P. Williams et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2020)

Article Chemistry, Medicinal

Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors

Brian A. Lanman et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Pharmacology & Pharmacy

Amoxicillin Inactivation by Thiol-Catalyzed Cyclization Reduces Protein Haptenation and Antibacterial Potency

Maria A. Pajares et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Dermatology

Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors

Vincent Sibaud et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)

Article Chemistry, Multidisciplinary

Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs

Michael J. Bond et al.

ACS CENTRAL SCIENCE (2020)

Article Medicine, General & Internal

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

David S. Hong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Bardoxolone conjugation enables targeted protein degradation of BRD4

Bingqi Tong et al.

SCIENTIFIC REPORTS (2020)

Article Gastroenterology & Hepatology

Exosomal Transport of Hepatocyte-Derived Drug-Modified Proteins to the Immune System

Monday O. Ogese et al.

HEPATOLOGY (2019)

Review Pharmacology & Pharmacy

Mechanisms of soft and hard electrophile toxicities

Richard M. LoPachin et al.

TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16

Xiaoyu Zhang et al.

NATURE CHEMICAL BIOLOGY (2019)

Article Chemistry, Medicinal

Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo

Arun Tailor et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2019)

Article Allergy

Identification and characterization of a naive CD8+T cell repertoire for benzylpenicillin

Rami Bechara et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2019)

Review Environmental Sciences

Protein Adductomics: Analytical Developments and Applications in Human Biomonitoring

George W. Preston et al.

TOXICS (2019)

Article Toxicology

Novel risk assessment of reactive metabolites from discovery to clinical stage

Nobuyuki Kakutani et al.

JOURNAL OF TOXICOLOGICAL SCIENCES (2019)

Review Biochemistry & Molecular Biology

Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation

Tinghu Zhang et al.

CELL CHEMICAL BIOLOGY (2019)

Article Allergy

β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells

Andrew Sullivan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Article Immunology

Specific MHC-I Peptides Are Induced Using PROTACs

Stephanie M. Jensen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Chemistry, Medicinal

Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future

Gabriele Sabbioni et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2017)

Article Pharmacology & Pharmacy

Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile

Tjeerd Barf et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Article Chemistry, Medicinal

Dapsone and Nitroso Dapsone Activation of Naive T-Cells from Healthy Donors

Abdulaziz Alzahrani et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2017)

Article Chemistry, Medicinal

Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts

Mohammed O. Amali et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2017)

Review Chemistry, Medicinal

Mass Spectrometric and Functional Aspects of Drug-Protein Conjugation

Arun Tailor et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2016)

Article Chemistry, Medicinal

Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients

Xiaoli Meng et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2016)

Article Medicine, Research & Experimental

The Use of Peptide Reactivity Assays for Skin Sensitisation Hazard Identification and Risk Assessment

G. Frank Gerberick

ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2016)

Review Cell Biology

Autoradiography techniques and quantification of drug distribution

Eric G. Solon

CELL AND TISSUE RESEARCH (2015)

Editorial Material Gastroenterology & Hepatology

Inhibition of immune tolerance unmasks drug-induced allergic hepatitis

Jack Uetrecht et al.

HEPATOLOGY (2015)

Letter Allergy

Promiscuous T-cell responses to drugs and drug-haptens

Fiazia S. Yaseen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Immunology

The effect of haptens on protein-carrier immunogenicity

Tal Gefen et al.

IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

Abacavir-Reactive Memory T Cells Are Present in Drug Naive Individuals

Andrew Lucas et al.

PLOS ONE (2015)

Review Oncology

Mechanisms underlying skin disorders induced by EGFR inhibitors

Martin Holcmann et al.

MOLECULAR & CELLULAR ONCOLOGY (2015)

Article Chemistry, Medicinal

HLA Restriction of Carbamazepine-Specific T-Cell Clones from an HLA-A*31:01-Positive Hypersensitive Patient

Maike Lichtenfels et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2014)

Article Chemistry, Medicinal

Abacavir Forms Novel Cross-Linking Abacavir Protein Adducts in Patients

Xiaoli Meng et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2014)

Article Oncology

Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase

Matthew S. Davids et al.

FUTURE ONCOLOGY (2014)

Article Multidisciplinary Sciences

Study of Protein Haptenation by Amoxicillin Through the Use of a Biotinylated Antibiotic

Adriana Ariza et al.

PLOS ONE (2014)

Article Allergy

DRESS syndrome induced by piperacillin-tazobactam

Maria-Jose Sanchez-Gonzalez et al.

Clinical and Translational Allergy (2014)

Article Chemistry, Medicinal

Detection of Drug Bioactivation in Vivo: Mechanism of Nevirapine-Albumin Conjugate Formation in Patients

Xiaoli Meng et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2013)

Editorial Material Oncology

TARGETED THERAPIES Afatinib-new therapy option for EGFR-mutant lung cancer

Helena A. Yu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

Article Chemistry, Medicinal

Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds

Melanie Z. Sakatis et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2012)

Article Chemistry, Medicinal

In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs

Richard A. Thompson et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2012)

Article Immunology

Avidity determines T-cell reactivity in abacavir hypersensitivity

Jacqueline Adam et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Article Multidisciplinary Sciences

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

Patricia T. Illing et al.

NATURE (2012)

Article Multidisciplinary Sciences

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

David A. Ostrov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Pharmacology & Pharmacy

Characterization of the Antigen Specificity of T-Cell Clones from Piperacillin-Hypersensitive Patients with Cystic Fibrosis

Sabah El-Ghaiesh et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)

Article Allergy

Immune pathomechanism of drug hypersensitivity reactions

Werner J. Pichler et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Allergy

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

Tai-Ming Ko et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Dermatology

Drug hypersensitivity: Flare-up reactions, cross-reactivity and multiple drug hypersensitivity

Werner J. Pichler et al.

JOURNAL OF DERMATOLOGY (2011)

Article Pharmacology & Pharmacy

Direct Evidence for the Formation of Diastereoisomeric Benzylpenicilloyl Haptens from Benzylpenicillin and Benzylpenicillenic Acid in Patients

Xiaoli Meng et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Review Biotechnology & Applied Microbiology

Managing the challenge of chemically reactive metabolites in drug development

B. Kevin Park et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Review Biochemistry & Molecular Biology

T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays

Stefan F. Martin et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2010)

Article Allergy

Stimulation of human T cells with sulfonamides and sulfonamide metabolites

J. Luis Castrejon et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Chemistry, Medicinal

Covalent Binding of Penicillamine to Macrophages: Implications for Penicillamine-Induced Autoimmunity

Jinze Li et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2009)

Article Pharmacology & Pharmacy

A Trapping Method for Semi-quantitative Assessment of Reactive Metabolite Formation Using [S-35]Cysteine and [C-14]Cyanide

Kazuko Inoue et al.

DRUG METABOLISM AND PHARMACOKINETICS (2009)

Article Pharmacology & Pharmacy

Danger Conditions Increase Sulfamethoxazole-Protein Adduct Formation in Human Antigen-Presenting Cells

S. N. Lavergne et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Biochemical Research Methods

Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo

Rosalind E. Jenkins et al.

PROTEOMICS CLINICAL APPLICATIONS (2009)

Article Medicine, General & Internal

HLA-B*5701 screening for hypersensitivity to abacavir

Simon Mallal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Chemistry, Multidisciplinary

An evaluation of the implementation of the Cramer classification scheme in the Toxtree software

G. Patlewicz et al.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2008)

Article Biochemical Research Methods

Study on the formation of an amoxicillin adduct with methanol using electrospray ion trap tandem mass spectrometry

Svetlana Grujic et al.

RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)

Article Pharmacology & Pharmacy

Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells

Sanjoy Roychowdhury et al.

DRUG METABOLISM AND DISPOSITION (2007)

Article Dermatology

Investigation of mechanisms underlying the T-cell response to the hapten 2,4-dinitrochlorobenzene

Chris Pickard et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)

Article Pharmacology & Pharmacy

Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450

Piyush M. Vyas et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Article Pharmacology & Pharmacy

Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts

Payal Bhaiya et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)

Article Allergy

Activation of T cells by carbamazepine and carbamazepine metabolites

Ying Wu et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Article Pharmacology & Pharmacy

Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes

S Roychowdhury et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Review Biochemistry & Molecular Biology

A comprehensive listing of bioactivation pathways of organic functional groups

AS Kalgutkar et al.

CURRENT DRUG METABOLISM (2005)

Article Medicine, General & Internal

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients

M Pirmohamed et al.

BMJ-BRITISH MEDICAL JOURNAL (2004)

Article Biochemistry & Molecular Biology

The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes

JS Walsh et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2002)

Article Pharmacology & Pharmacy

Haptenation of sulfonamide reactive metabolites to cellular proteins

T Manchanda et al.

MOLECULAR PHARMACOLOGY (2002)

Review Allergy

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

Werner J. Pichler

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2002)